Pharmacokinetics of cisplatin in the absence or presence of Zengmian Yiliu granules (a traditional Chinese medicine compound) in rats determined via ICP-MS: An investigation on drug–herb interactions

References

• Alderden RA, Hall MD, Hambley TW. (2006). The discovery and development of cisplatin. J Chem Educ 83:728–34
   Web of Science ®Google Scholar
• Attia SM. (2011). Influence of resveratrol on oxidative damage in genomic DNA and apoptosis induced by cisplatin. Mutat Res Gen Tox EM 741:22–31
   PubMed Web of Science ®Google Scholar
• Besançon OG, Tytgat GAM, Meinsma R, et al. (2012). Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and muticellular tumor spheroids. Cancer Lett 319:23–30
   PubMed Web of Science ®Google Scholar
• Cao Y, Xia QH, Ma H, Zhong AP. (2008). Pharmacological effects of serum containing Chinese medicine Bushen Huayu Jiedu compound recipe in lung cancer drug-resistance cells. Chin J Integr Med 14:46–50
   PubMed Web of Science ®Google Scholar
• Chen C, Wang HC, An X, et al. (2012). Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma. Cancer Chemother Pharmacol 11:1–8
   Google Scholar
• Chen LG, Hung LY, Tsai KW, et al. (2008). Wogonin, a bioactive flavonoid in herbal tea, inhibits inflammatory cyclooxygenase-2 gene expression in human lung epithelial cancer cells. Mol Nutr Food Res 52:1349–57
   PubMed Web of Science ®Google Scholar
• Du Souich P, Verges J, Erill S. (1993). Plasma protein binding and pharmacological response. Clin Pharmacokinet 24:435–5
   PubMed Web of Science ®Google Scholar
• Dwivedi C, Agrawal P, Natarajan K, Sharma H. (2005). Antioxidant and protective effects of amrit nectar tablets on adriamycin- and cisplatin-induced toxicities. J Alternat Complement Med 11:143–8
   PubMed Web of Science ®Google Scholar
• Erdlenbruch B, Nier M, Kern W, et al. (2001). Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients. Eur J Clin Pharmacol 57:393–402
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Perrier D. (1977). Drug distribution in renal failure. Am J Med 62:471–4
   PubMed Web of Science ®Google Scholar
• Gong C, Qian L, Yang H, et al. (2014). Simultaneous determination of five active ingredients in Zengmian Yiliu granules by UPLC-MS. Chin Tradit Patent Med 36:301–5
   Google Scholar
• Hanada T, Isobe H, Saitoh T, et al. (1998). Inductively coupled plasma mass spectrometry for the determination of platinum accumulation in human non-small cell lung cancer cell lines. Int J Clin Oncol 3:98–101
   Google Scholar
• Hu XX, Zhang QH, Qi C, Li JX. (2012). Anti-angiogenic effects of Zengmian Yiliu granule on ovarian carcinoma xenograft. Chin J Integr Med 32:970–4
   Google Scholar
• Huang ZH, Qi C, Zhang QH. (2004). Effect on bcl-2, bax gene expression in rat with ovarian cancer treated by cisplatin and “Zengmian Yiliu Mixture”. J Tradit Chin Med 2:63–5
   Google Scholar
• Johnsson A, Björk H, Schütz A, Skärby T. (1997). Sample handling for determination of free platinum in blood after cisplatin exposure. Cancer Chemother Pharmacol 41:248–51
   Web of Science ®Google Scholar
• Johnsson A, Höglund P, Grubb A, Cavallin-Sta E. (1996). Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus. Cancer Chemother Pharmacol 39:25–33
   PubMed Web of Science ®Google Scholar
• Johnsson A, Olsson C, Nygren O, et al. (1995). Pharmacokinetics and tissue distribution of cisplatin in nude mice: Platinum levels and cisplatin-DNA adducts. Cancer Chemother Pharmacol 37:23–31
   PubMed Web of Science ®Google Scholar
• Laghari AJ, Khuhawar MY, Zardari LA, Bhatti AG. (2008). GC determination of cisplatin in serum and urine of cancer patients after chemotherapy as platinum (II) pyrrolidinedithiocarbamate chelate. Chromatographia 67:749–54
   Web of Science ®Google Scholar
• Li JX, Zhang QH, Hu XX, Qi C. (2012). Effects of Zengmian Yiliu decoction on expression of resistance related genes HIF-1, Glut1, MDR1, P-gp in nude mice with cisplatin-resistant ovarian cancer. J Tradit Chin Med 46:61–4
   Google Scholar
• Mills PC, Ng JC, Auer DE. (1997). The effect of the acute-phase response on in vitro drug metabolism and plasma protein binding in the horse. Vet Res Commun 21:361–8
   PubMed Web of Science ®Google Scholar
• Minakata K, Suzuki M, Nozawa H, et al. (2006). Platinum levels in various tissues of a patient who died 181 days after cisplatin overdosing determined by electrospray ionization mass spectrometry. Forensic Toxicol 24:83–7
   Google Scholar
• Minami T, Ichii M, Okazaki Y. (1995). Comparison of three different methods for measurement of tissue platinum level. Biol Trace Elem Res 48:37–45
   PubMed Web of Science ®Google Scholar
• Nygren O, Lundgren C. (1997). Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy. Int Arch Occ Env Hea 70:209–14
   PubMed Web of Science ®Google Scholar
• Paksoy M, Ayduran E, Sanli A, et al. (2011). The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol 28:615–21
   PubMed Web of Science ®Google Scholar
• Park HR, Ju EJ, Jo SK, et al. (2009). Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice. BMC Cancer 9:85–95
   PubMed Web of Science ®Google Scholar
• Qi C, Zhang QH, Li JX, Hu XX. (2012). Effects of Zengmian Yiliu recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer. Chin J Integr Med 32:817–21
   Google Scholar
• Rosenberg B. (1985). Fundamental studies with cisplatin. Cancer 55:2303–16
   PubMed Web of Science ®Google Scholar
• Suddek GM. (2010). Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals. Cancer Chemother Pharmacol 67:1035–44
   PubMed Web of Science ®Google Scholar
• Türk G, Ateşşahin A, Sőnmez M, et al. (2008). Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid. Fertil Steril 89:1474–81
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Vander Vijgh WJ, Klein I, et al. (1984). Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep 68:505–13
   PubMedGoogle Scholar
• Wang CZ, Fishbein A, Aung HH, et al. (2005). Polyphenol contents in grape-seed extracts correlate with antipica effects in cisplatin-treated rats. J Alternat Complement Med 11:1059–65
   PubMed Web of Science ®Google Scholar
• Wang D, Song MS, Yang GL. (2003). Protein binding study of perillyl alcohol enantiomers by high performance frontal analysis. J Liq Chromatogr RT 26:2861–71
   Web of Science ®Google Scholar
• Xian GY, Wang S. (2010). The research of Zingiberis recentis decoction for purging stomach-fire against cisplatin-induced vomiting in mice. Guide Chin Med 8:47–8
   Google Scholar
• Xu WZ, Zhou L, Ma XN, et al. (2011). Therapeutic effects of combination of paeoniflorin and albiflorin from Paeonia radix on radiation and chemotherapy-induced myelosuppression in mice and rabbits. Asian Pac J Cancer Prev 12:2031–7
   PubMedGoogle Scholar
• Yamada K, Kato N, Takati A, et al. (2005). One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): Determination of platinum-DNA adducts in cells treated with platinum (II) complexes. Anal Bioanal Chem 382:1702–7
   PubMed Web of Science ®Google Scholar
• Yu JQ, Liu HB, Lei JC, et al. (2007). Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res 21:817–22
   PubMed Web of Science ®Google Scholar
• Zemlickis D, Klein J, Moselhy G, Koren G. (2006). Cisplatin protein binding in pregnancy and the neonatal period. Med Pediatr Oncol 23:476–9
   Google Scholar
• Zhang QH, Hu XX, Qi C, Li JX. (2011). Experimental study on regulating effects of Zengmian Yiliu granule on immunosuppression and myelosuppression following large-dose chemotherapy in ovarian carcinoma. J Tradit Chin Med 45:71–4
   Google Scholar
• Zhang QH, Qi C, Wang RJ. (2012). Influence of Zengmian Yiliu granule on quality of life in patients with advanced ovarian cancer during chemotherapy period. J Tradit Chin Med 46:41–4
   Google Scholar